FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Belladonna and Opium Suppository
Status: Currently in Shortage
»Date first posted: 05/09/2018
»Therapeutic Categories: Urology

Expand all

Perrigo Pharmaceuticals (Reverified 07/27/2018)

Company Contact Information:
269-673-8451

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Belladonna 16.2 mg and Opium 60 mg Suppositories 12-count (NDC 0574-7040-12) Unavailable; Anticipated resupply is Q4 2018 Manufacturing delay due to active ingredient shortage Shortage of an active ingredient
Belladonna 16.2 mg and Opium 30 mg Suppositories 12-count (NDC 0574-7045-12) Unavailable; Anticipated resupply is Q4 2018 Manufacturing delay due to active ingredient shortage Shortage of an active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English